AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 96 filers reported holding AQUESTIVE THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.78 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $34,932 | +773.3% | 8,200 | +118.6% | 0.00% | – |
| Q3 2022 | $4,000 | +100.0% | 3,751 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | -77.8% | 3,751 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $9,000 | +50.0% | 3,751 | +167.9% | 0.00% | – |
| Q3 2021 | $6,000 | -57.1% | 1,400 | -49.7% | 0.00% | -100.0% |
| Q4 2020 | $14,000 | – | 2,783 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bratton Capital Management, L.P. | 9,810,958 | $8,849,484 | 100.00% |
| Vahanian & Associates Financial Planning Inc. | 678,258 | $611,857 | 2.00% |
| Latash Investments, LLC | 243,134 | $219,331 | 0.18% |
| Bracebridge Capital, LLC | 428,571 | $386,614 | 0.04% |
| D.B. Root & Company, LLC | 12,500 | $11,276 | 0.01% |
| Schonfeld Strategic Advisors LLC | 506,600 | $457,004 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 142,956 | $128,961 | 0.00% |
| IFP Advisors, Inc | 6,500 | $104 | 0.00% |
| Financial Advocates Investment Management | 32,000 | $28,867 | 0.00% |
| Richard W. Paul & Associates, LLC | 1,423 | $1,284 | 0.00% |